Novartis Oncology Director of Business Development Salaries in New York
The average Novartis Oncology Director of Business Development in New York earns an estimated $205,788 annually, which includes an estimated base salary of $159,550 with a $46,238 bonus. Novartis Oncology's Director of Business Development compensation is $39,522 more than the US average for a Director of Business Development. Director of Business Development salaries at Novartis Oncology in New York can range from $120,000 - $290,000.
In New York, The Business Development Department at Novartis Oncology earns $2,821 more on average than the Engineering Department.
Last updated 3 years ago.
- $159,550
- avg. base
- $46,238
- avg. bonus
Director of Business Development Salaries at Novartis Oncology
In New York, Directors of Business Development earn $6,346 more than Directors of Business Development.
Compensation at Novartis Oncology by Department
In New York, The Business Development Department averages $2,821 more than the Engineering Department, and $10,199 less than the Product Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Novartis Oncology reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Novartis Oncology reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Novartis Oncology Rate Their Compensation
The majority of Directors of Business Development at Novartis Oncology believe they're not compensated fairly. 100% of Directors of Business Development at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
